This season, the effectiveness of the flu vaccine was estimated at around 59% among those under 65 with risk factors, compared to 38% among those over 65.
This difference is explained in particular by the predominance of type A viruses, more virulent and changing subjects, as well as by the lower immune response in seniors.
Despite this moderate efficiency, vaccination remains essential to reduce serious forms and hospitalizations. It is now crucial to integrate so -called “improved” vaccines in our older protection strategy.
Whether high -dose vaccines, added or innovative technology, these formulations are specifically designed to better stimulate the immune system for the elderly. Makeing them available for the next season could represent a decisive progress to strengthen prevention efficiency.
The tracks to consider to make the next vaccination campaign a real lever for the protection of populations
1. Enter the vaccination even more clearly in the main priorities of 2026, to guarantee a sustainable health system and resilient economy.
2. Awareness of the general public: fear or vaccination hesitation must be fought by clear and accessible information. To vaccinate against flu is also to protect yourself from other pathologies.
3. Mobilize companies: integrate all vaccinations in occupational health policies.
4. Support the most vulnerable: facilitate access to vaccination for isolated and vulnerable populations in a first leg.
5. Make you available for improved vaccines for those over 65 for the next vaccination season.
